INS and metabolic syndrome: This dual-marker approach captures both β-cell dysfunction (reflected by glucose elevation) and dysregulated adipose tissue lipolysis (manifested as triglyceride accumulation), thereby providing higher sensitivity for early insulin signaling impairment detection compared to isolated hyperglycemia or dyslipidemia (13).